Sudden Cardiac Death in Athletes

Progress in Cardiovascular Diseases

Volumn 51, Issue 1, 2008, Pages 44-57

  Link, Mark S ^a   Mark Estes III, N A ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLECAINIDE;

ARTICLE; ATHLETE; BRUGADA SYNDROME; CARDIOVASCULAR RISK; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CORONARY ARTERY DISEASE; DEFIBRILLATOR; HEART ARREST; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; LONG QT SYNDROME; PATHOPHYSIOLOGY; PREVALENCE; SHORT QT SYNDROME; SUDDEN DEATH;

ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; CORONARY DISEASE; DEATH, SUDDEN, CARDIAC; HUMANS; RISK FACTORS; SPORTS;

EID: 46849108709     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2007.10.002     Document Type: Article

References (79)

1. Maron B.J., Douglas P.S., Graham T.P., et al. Task Force 1: preparticipation screening and diagnosis of cardiovascular disease in athletes. J Am Coll Cardiol 45 (2005) 1322-1326
2. Pelliccia A., Maron B.J., Spataro A., et al. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 324 (1991) 295-301
3. Pelliccia A., Culasso F., Di Paolo F.M., et al. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med 130 (1999) 23-31
4. Wharton J. "Athlete's heart": the medical debate over athleticism, 1870-1920. In: Berryman J.W., and Park R.J. (Eds). Sport and exercise science, essays in the history of sports medicine (1992), University of Illinois Press, Urbana (Ill)
5. Rost R. The athlete's heart. Historical perspectives-solved and unsolved problems. Cardiol Clin 15 (1997) 493-512
6. Abernethy W.B., Choo J.K., and Hutter Jr. A.M. Echocardiographic characteristics of professional football players. J Am Coll Cardiol 41 (2003) 280-284
7. Scharhag J., Schneider G., Urhausen A., et al. Athlete's heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol 40 (2002) 1856-1863
8. Maron B.J. Distinguishing hypertrophic cardiomyopathy from athlete's heart: a clinical problem of increasing magnitude and significance. Heart 91 (2005) 1380-1382
9. Maron B.J., and Pelliccia A. The heart of trained athletes: cardiac remodeling and the risks of sports, including sudden death. Circulation 114 (2006) 1633-1644
10. Pelliccia A., Maron B.J., Culasso F., et al. Athlete's heart in women. Echocardiographic characterization of highly trained elite female athletes. JAMA 276 (1996) 211-215
11. Pelliccia A., Maron B.J., Culasso F., et al. Clinical significance of abnormal electrocardiographic patterns in trained athletes. Circulation 102 (2000) 278-284
12. Serra-Grima R., Estorch M., Carrio I., et al. Marked ventricular repolarization abnormalities in highly trained athletes' electrocardiograms: Clinical and prognostic implications. J Am Coll Cardiol 36 (2000) 1310-1316
13. Chapman J. Profound sinus bradycardia in the athletic heart syndrome. J Sports Med Phys Fitness 22 (1981) 294-298
14. Biffi A., Pelliccia A., Verdile L., et al. Long-term clinical significance of frequent and complex ventricular tachyarrhythmias in trained athletes. J Am Coll Cardiol 40 (2002) 446-452
15. Talan D.A., Bauernfeind R.A., Ashley W.W., et al. Twenty-four hour continuous ECG recordings in long-distance runners. Chest 82 (1982) 19-24
16. Zehender M., Meinertz T., Keul J., et al. ECG variants and cardiac arrhythmias in athletes: clinical relevance and prognostic importance. Am Heart J 119 (1990) 1378-1391
17. Douglas P.S., O'Toole M.L., Hiller W.D., et al. Electrocardiographic diagnosis of exercise-induced left ventricular hypertrophy. Am Heart J 116 (1988) 784-790
18. Balady G.J., Cadigan J.B., and Ryan T.J. Electrocardiogram of the athlete: an analysis of 289 professional football players. Am J Cardiol 53 (1984) 1339-1343
19. Maron B.J. Cardiovascular risks to young persons on the athletic field. Ann Intern Med 129 (1998) 379-386
20. Corrado D., Basso C., Rizzoli G., et al. Does sports activity enhance the risk of sudden death in adolescents and young adults?. J Am Coll Cardiol 42 (2003) 1959-1963
21. Maron B.J., Gardin J.M., Flack J.M., et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 92 (1995) 785-789
22. Corrado D., Basso C., Schiavon M., et al. Screening for hypertrophic cardiomyopathy in young athletes. N Engl J Med 339 (1998) 364-369
23. Maron B.J. Sudden death in young athletes. N Engl J Med 349 (2003) 1064-1075
24. Puranik R., Chow C.K., Duflou J.A., et al. Sudden death in the young. Heart Rhythm 2 (2005) 1277-1282
25. Ellsworth E.G., and Ackerman M.J. The changing face of sudden cardiac death in the young. Heart Rhythm 2 (2005) 1283-1285
26. Maron B.J., Ackerman M.J., Nishimura R.A., et al. Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome. 36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities. J Am Coll Cardiol 45 (2005) 1340-1345
27. Frenneaux M.P. Assessing the risk of sudden cardiac death in a patient with hypertrophic cardiomyopathy. Heart 90 (2004) 570-575
28. Maron B.J., Moller J.H., Seidman C.E., et al. Impact of laboratory molecular diagnosis on contemporary diagnostic criteria for genetically transmitted cardiovascular diseases: hypertrophic cardiomyopathy, long QT syndrome, and Marfan syndrome. Circulation 98 (1998) 1460-1471
29. Elliott P.M., Blanes J.R.G., Mahan N.G., et al. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 357 (2001) 420-424
30. Maron B.J., Spirito P., Shen W.K., et al. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy. JAMA 298 (2007) 405-412
31. Corrado D., Leoni L., Link M.S., et al. Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia. Circulation 108 (2003) 3084-3091
32. Hulot J.S., Jouven X., Empana J.P., et al. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 110 (2004) 1879-1884
33. Roguin A., Bomma C.S., Nasir K., et al. Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 43 (2004) 1843-1852
34. Wichter T., Paul M., Wollmann C., et al. Implantable cardioverter/defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy: single-center experience of long-term follow-up and complications in 60 patients. Circulation 109 (2004) 1503-1508
35. Zipes D.P., Ackerman M.J., Estes III N.A.M., et al. Task Force 7: Arrhythmias. 36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities. J Am Coll Cardiol 45 (2005) 43-52
36. Corrado D., Basso C., Poletti A., et al. Sudden death in the young. Is acute coronary thrombosis the major precipitating factor?. Circulation 90 (1994) 2315-2323
37. Thompson P.D., Balady G.J., Chaitman B.R., et al. Task Force 6: coronary artery disease. J Am Coll Cardiol 45 (2005) 1348-1353
38. Basso C., Corrado D., and Thiene G. Congenital coronary artery anomalies as an important cause of sudden death in the young. Cardiol Rev 9 (2001) 312-317
39. Graham Jr. T.P., Driscoll D.J., Gersony W.M., et al. Task Force 2: congenital heart disease. J Am Coll Cardiol 45 (2005) 1326-1333
40. Wellens H.J. Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? When to perform catheter ablation in asymptomatic patients with a Wolff-Parkinson-White electrocardiogram. Circulation 112 (2005) 2201-2207 [discussion 16]
41. Pappone C., and Santinelli V. Should catheter ablation be performed in asymptomatic patients with Wolff-Parkinson-White syndrome? Catheter ablation should be performed in asymptomatic patients with Wolff-Parkinson-White syndrome. Circulation 112 (2005) 2207-2215 [discussion 16]
42. Chugh S.S., Senashova O., Watts A., et al. Postmortem molecular screening in unexplained sudden death. J Am Coll Cardiol 43 (2004) 1625-1629
43. Tester D.J., Spoon D.B., Valdivia H.H., et al. Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases. Mayo Clin Proc 79 (2004) 1380-1384
44. Kass R.S., and Moss A.J. Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias. J Clin Invest 112 (2003) 810-815
45. Schwartz P.J., Priori S.G., Spazzolini C., et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103 (2001) 89-95
46. Tester D.J., Will M.L., Haglund C.M., et al. Effect of clinical phenotype on yield of long QT syndrome genetic testing. J Am Coll Cardiol 47 (2006) 764-768
47. Vyas H., Hejlik J., and Ackerman M.J. Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response. Circulation 113 (2006) 1385-1392
48. Moss A.J., Zareba W., Hall W.J., et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 101 (2000) 616-623
49. Antzelevitch C., Brugada P., Borggrefe M., et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 111 (2005) 659-670
50. Priori S.G., Napolitano C., Gasparini M., et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 105 (2002) 1342-1347
51. Brugada J., Brugada R., and Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 108 (2003) 3092-3096
52. Eckardt L., Probst V., Smits J.P., et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 111 (2005) 257-263
53. Gaita F., Giustetto C., Bianchi F., et al. Short QT syndrome: a familial cause of sudden death. Circulation 108 (2003) 965-970
54. Maron B.J., Doerer J.J., Haas T.S., et al. Historical observation on commotio cordis. Heart Rhythm 3 (2006) 605-606
55. Maron B.J., Gohman T.E., Kyle S.B., et al. Clinical profile and spectrum of commotio cordis. JAMA 287 (2002) 1142-1146
56. Nesbitt A.D., Cooper P.J., and Kohl P. Rediscovering commotio cordis. Lancet 357 (2001) 1195-1197
57. Maron B.J., Poliac L.C., Kaplan J.A., et al. Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med 333 (1995) 337-342
58. Maron B.J., Wentzel D.C., Zenovich A.G., et al. Death in a young athlete due to commotio cordis despite prompt external defibrillation. Heart Rhythm 2 (2005) 991-993
59. Drezner J.A., and Rogers K.J. Sudden cardiac arrest in intercollegiate athletes: detailed analysis and outcomes of resuscitation in nine cases. Heart Rhythm 3 (2006) 755-759
60. Link M.S. Resuscitation in athletes: a sobering tale. Heart Rhythm 3 (2006) 760-761
61. Link M.S., Wang P.J., Pandian N.G., et al. An experimental model of sudden death due to low-energy chest-wall impact (commotio cordis). N Engl J Med 338 (1998) 1805-1811
62. Link M.S., Maron B.J., VanderBrink B.A., et al. Impact directly over the cardiac silhouette is necessary to produce ventricular fibrillation in an experimental model of commotio cordis. J Am Coll Cardiol 37 (2001) 649-654
63. Link M.S., and Estes III N.A. Mechanically induced ventricular fibrillation (commotio cordis). Heart Rhythm 4 (2007) 529-532
64. Link M.S., Maron B.J., Wang P.J., et al. Upper and lower limits of vulnerability to sudden arrhythmic death with chest-wall impact (commotio cordis). J Am Coll Cardiol 41 (2003) 99-104
65. Link M.S., Maron B.J., Wang P.J., et al. Reduced risk of sudden death from chest wall blows (commotio cordis) with safety baseballs. Pediatrics 109 (2002) 873-877
66. Bode F., Franz M.R., Wilke I., et al. Ventricular fibrillation induced by stretch pulse: implications for sudden death due to commotio cordis. J Cardiovasc Electrophysiol 17 (2006) 1011-1017
67. Link M.S. Mechanically induced sudden death in chest wall impact. Prog Biophys Mol Biol 82 (2003) 175-186
68. Kohl P., Nesbitt A.D., Cooper P.J., et al. Sudden cardiac death by commotio cordis: role of mechanico-electrical feedback. Cardiovasc Res 50 (2001) 280-289
69. Kohl P., and Ravens U. Cardiac mechano-electric feedback: past, present, and prospect. Prog Biophys Mol Biol 82 (2003) 3-9
70. Link M.S., Wang P.J., VanderBrink B.A., et al. Selective activation of the K(+)(ATP) channel is a mechanism by which sudden death is produced by low-energy chest-wall impact (commotio cordis). Circulation 100 (1999) 413-418
71. Van Wagoner D.R. Mechanosensitive gating of atrial ATP-sensitive potassium channels. Circ Res 72 (1993) 973-983
72. Weinstock J., Maron B.J., Song C., et al. Failure of commercially available chest wall protectors to prevent sudden cardiac death induced by chest wall blows in an experimental model of commotio cordis. Pediatrics 117 (2006) e656-e662
73. Maron B.J., Estes III N.A., and Link M.S. Task Force 11: Commotio cordis: 36th Bethesda Conference: Eligibility Recommendations for Competitive Athletes with Cardiovascular Abnormalities. J Am Coll Cardiol 45 (2005) 1371-1373
74. Kramer M.R., Drori Y., and Lev B. Sudden death in young soldiers: high incidence of syncope prior to death. Chest 93 (1988) 345-347
75. Link M.S., Wang P.J., and Estes III N.A.M. Cardiac arrhythmias and electrophysiologic observations in the athlete. In: Richard A., and Williams M. (Eds). The athlete and heart disease (1998), Lippincott Williams & Wilkins, Philadelphia 197-216
76. Savage D., Seides S., Clark C., et al. Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation 58 (1978) 402-408
77. Wigle E.D., Rakowski H., Kimball B.P., et al. Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 92 (1995) 1680-1692
78. Vincent G.M., Timothy K.W., Leppert M., et al. The spectrum of symptoms and QT intervals in carriers of the gene for the long QT syndrome. N Engl J Med 327 (1992) 846-852
79. Corrado D., Basso C., Pavei A., et al. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 296 (2006) 1593-1601